drugset

drugset / Trial / NCT03026946

Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema

NCT03026946 ↗

Phase 3 Unknown 76 enrolled University Medical Center Groningen ZonMw: The Netherlands Organisation for Health Research and Development · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy of alitretinoin and cyclosporine in the treatment of patients with severe recurrent vesicular hand eczema.

Timeline

Start: 2017-05-29
Primary completion: 2022-07
Completion: 2022-07

Publications

Oosterhaven JAF, Schuttelaar MLA. Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment. BMJ Open. 2018 Jul 11;8(7):e020192. doi: 10.1136/bmjopen-2017-020192.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Cyclosporine	Peptide	3 mg/kg	Oral
Comparator	Cyclosporine	Peptide	3.5 mg/kg	Oral
Comparator	alitretinoin	Other / unclassified	30 mg	Oral

Indications